Facebook tracking pixel
H90.2
ICD-10-CM
Conductive Hearing Loss

Understanding Conductive Hearing Loss (CHL): Explore symptoms, causes, diagnosis, and treatment options for CHL, also known as Conductive Deafness. Find information on audiometry testing, medical coding for Conductive Hearing Loss, and clinical documentation best practices. Learn about hearing aids and other assistive devices used in managing CHL. This resource provides valuable insights for healthcare professionals, patients, and coders seeking information related to the C diagnosis of Conductive Hearing Loss.

Also known as

CHL
Conductive Deafness

Diagnosis Snapshot

Key Facts
  • Definition : Hearing loss due to sound conduction problems in the outer or middle ear.
  • Clinical Signs : Reduced hearing, muffled sounds, speaks softly, air-bone gap on testing.
  • Common Settings : Primary care, ENT clinics, audiology departments, hospitals.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC H90.2 Coding
H90-H90

Conductive and sensorineural hearing loss

Hearing loss due to problems with the outer or middle ear and inner ear or auditory nerve.

H91-H91

Other hearing loss

Hearing loss not classified as conductive or sensorineural, including sudden deafness.

H60-H95

Diseases of the ear and mastoid process

Includes various ear conditions, infections, and hearing disorders.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the conductive hearing loss unilateral?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Hearing loss due to outer/middle ear problems.
Hearing loss due to inner ear or nerve damage.
Hearing loss with both conductive and sensorineural components.

Documentation Best Practices

Documentation Checklist
  • Document air and bone conduction thresholds.
  • Specify CHL laterality (unilateral, bilateral).
  • Describe onset (sudden, gradual), duration.
  • Note any identifiable cause (e.g., cerumen, otitis media).
  • Record impact on speech understanding.

Coding and Audit Risks

Common Risks
  • Laterality Coding

    Missing or incorrect laterality (right, left, bilateral) for conductive hearing loss can lead to inaccurate coding and claims.

  • CHL Etiology Specificity

    Lack of documentation specifying the underlying cause of CHL (e.g., cerumen, otitis media) can affect code selection and reimbursement.

  • CHL vs. SNHL Confusion

    Misdiagnosis or unclear differentiation between conductive and sensorineural hearing loss may result in inappropriate coding and treatment.

Mitigation Tips

Best Practices
  • Amplification devices (hearing aids, BAHA)
  • Treat underlying causes (e.g., infections, cerumen)
  • Surgical intervention (e.g., tympanoplasty, ossiculoplasty)
  • Regular audiological evaluations ICD-10 H90
  • Patient education and counseling CPT 92557

Clinical Decision Support

Checklist
  • Verify air conduction poorer than bone conduction (Weber/Rinne tests)
  • Confirm airbone gap >10 dB, indicating conductive loss
  • Check external/middle ear: obstruction, infection, otosclerosis
  • Review medications: ototoxic drugs impacting hearing
  • Document laterality (left, right, bilateral) and severity

Reimbursement and Quality Metrics

Impact Summary
  • Conductive Hearing Loss (CHL) reimbursement hinges on accurate ICD-10 coding (H90.-) for optimal claim processing and denial prevention.
  • Coding quality impacts CHL diagnosis reporting, affecting hospital quality metrics and pay-for-performance programs.
  • Accurate CHL coding ensures proper reimbursement for audiological tests, hearing aids, and surgical interventions.
  • Precise documentation of CHL etiology (e.g., otitis media, cholesteatoma) improves coding specificity and revenue integrity.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective differential diagnosis strategies for conductive hearing loss (CHL) in adults presenting with impacted cerumen versus middle ear effusion?

A: Differentiating between impacted cerumen and middle ear effusion, both common causes of conductive hearing loss in adults, requires a multi-faceted approach. Otoscopic examination is crucial: impacted cerumen appears as a dark brown or yellowish mass obstructing the ear canal, while middle ear effusion presents with a retracted or bulging tympanic membrane, often with an air-fluid level or altered color. Tympanometry helps distinguish the two: a flat tympanogram suggests middle ear fluid, while a normal tympanogram with reduced ear canal volume suggests cerumen impaction. Pure-tone audiometry typically reveals conductive hearing loss in both conditions, but bone conduction thresholds remain normal. Exploring pneumatic otoscopy can further enhance diagnostic accuracy by assessing tympanic membrane mobility. Consider implementing a standardized protocol incorporating these techniques to ensure accurate diagnosis and appropriate management for each condition. Explore how combining otoscopy, tympanometry, and audiometry improves diagnostic certainty in CHL cases.

Q: How can I distinguish between otosclerosis and other causes of conductive hearing loss when evaluating a young adult patient with gradual onset hearing loss and a normal tympanic membrane?

A: While a normal-appearing tympanic membrane can complicate the diagnosis of conductive hearing loss in young adults, it’s important to consider otosclerosis in the differential, especially with gradual onset. Although otosclerosis often presents with a reddish hue behind the tympanic membrane (Schwartze's sign), this isn't always visible. Crucially, differentiating it from other causes like ossicular chain discontinuity or congenital cholesteatoma requires careful audiological assessment. Carhart's notch, a characteristic bone-conduction dip at 2kHz, though not always present, can suggest otosclerosis. High-resolution CT imaging of the temporal bone is essential for visualizing the characteristic foci of otosclerosis affecting the stapes footplate. Learn more about the diagnostic value of comparing air and bone conduction thresholds at various frequencies, particularly at 2 kHz, in suspected otosclerosis cases. Explore the role of advanced imaging techniques in confirming otosclerosis and ruling out other subtle middle ear pathologies.

Quick Tips

Practical Coding Tips
  • Code H90 for CHL/Conductive Deafness
  • Document cause, laterality, severity
  • ICD-10 H90.x, specify subtype
  • Consider air-bone gap testing results
  • Check documentation for ossicular chain issues

Documentation Templates

Patient presents with complaints consistent with conductive hearing loss (CHL), also known as conductive deafness.  Symptoms include diminished hearing sensitivity, difficulty understanding speech in noisy environments, and a sensation of fullness or pressure in the affected ear(s).  Onset of symptoms was reported as [gradual/sudden] and began approximately [duration] ago.  Possible etiologies explored include cerumen impaction, otitis media, otosclerosis, cholesteatoma, and foreign body obstruction.  Physical examination revealed [describe findings, e.g., impacted cerumen in the right ear canal, retracted tympanic membrane, etc.].  Audiometric testing demonstrates air-bone gap confirming the conductive nature of the hearing loss.  Pure-tone audiometry results indicate [describe specific thresholds and frequencies affected].  Tympanometry findings suggest [describe type, e.g., Type B tympanogram indicative of middle ear effusion].  Diagnosis of conductive hearing loss is made based on patient history, physical examination findings, and audiological test results.  Treatment plan includes [describe treatment, e.g., cerumen removal, antibiotic therapy for otitis media, referral to otolaryngology for further evaluation and management of possible otosclerosis or cholesteatoma].  Patient education provided regarding the nature of conductive hearing loss, potential causes, treatment options, and expected outcomes.  Follow-up appointment scheduled for [date] to reassess hearing and monitor treatment response.  ICD-10 code H90.  Medical billing codes will be determined based on specific procedures performed.